abstract |
This invention uses our knowledge of the mechanisms by which antigen is recognizednby T cells to identify and prepare HER2/new epitopes, and to develop epitope-basednvaccines directed towards HERS2/neu-bearing tumors. More specifically, thisnapplication communicates our discovery of pharmaceutical compositions and methodsnof use in the prevention and treatment of cancer. |